Gilenya and Gastric cancer - a phase IV clinical study of FDA data

Summary:

Gastric cancer is found among people who take Gilenya, especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Gilenya and have Gastric cancer. It is created by eHealthMe based on reports of 106,924 people who have side effects when taking Gilenya from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

106,924 people reported to have side effects when taking Gilenya.
Among them, 11 people (0.01%) have Gastric cancer.


What is Gilenya?

Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 107,197 Gilenya users for its effectiveness, alternative drugs and more.

What is Gastric cancer?

Gastric cancer (stomach cancer) is found to be associated with 1,326 drugs and 896 conditions by eHealthMe.

Number of Gilenya and Gastric cancer reports submitted per year:

Could Gilenya cause Gastric cancer?

Time on Gilenya when people have Gastric cancer *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 60 %
  • 2 - 5 years: 40 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gastric cancer when taking Gilenya *:

  • female: 50 %
  • male: 50 %

Age of people who have Gastric cancer when taking Gilenya *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 0.0 %
  • 30-39: 42.86 %
  • 40-49: 0.0 %
  • 50-59: 42.86 %
  • 60+: 0.0 %

Common drugs people take besides Gilenya *:

  1. Tamsulosin: 2 people, 18.18%
  2. Remicade: 1 person, 9.09%
  3. Prednisone: 1 person, 9.09%

Common side effects people have besides Gastric cancer *:

  1. Weight Decreased: 2 people, 18.18%
  2. Oesophageal Disorder (disease of oesophagus): 2 people, 18.18%
  3. Eating Disorder: 2 people, 18.18%
  4. Linitis Plastica: 1 person, 9.09%
  5. Abdominal Pain Upper: 1 person, 9.09%
  6. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 9.09%
  7. Breast Cancer: 1 person, 9.09%
  8. Constipation: 1 person, 9.09%
  9. Cough: 1 person, 9.09%
  10. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 9.09%

Common conditions people have *:

  1. Nausea (feeling of having an urge to vomit): 1 person, 9.09%
  2. Iron Deficiency Anaemia: 1 person, 9.09%
  3. Insomnia (sleeplessness): 1 person, 9.09%
  4. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gilenya and have Gastric cancer?

Check whether Gastric cancer is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Gastric cancer and when was it recovered:

Expand to all the drugs that have ingredients of fingolimod:

Alternative drugs to, pros and cons of Gilenya:

Common Gilenya side effects:

Browse all side effects of Gilenya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gastric cancer treatments and more:

COVID vaccines that are related to Gastric cancer:

Common drugs associated with Gastric cancer:

All the drugs that are associated with Gastric cancer:

Common conditions associated with Gastric cancer:

All the conditions that are associated with Gastric cancer:

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod (the active ingredients of Gilenya) and Gilenya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: